Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
ASX Health Stocks: Invex granted orphan drug designation in Europe; Resonance has a new CEO
Argenica’s ARG-007 shows promise in treating traumatic brain injury
ASX Health Stocks: Here’s why AHI shares jump 40pc on the ASX, and more than 100pc on Nasdaq
ASX Health Stocks: BOD to sell cannabis in Malaysia; AHI explores the burgeoning Middle East e-script market
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
ASX-listed Zelira is going head-to-head with Big Pharma. We spoke to its CEO about its place in a US$62 billion market
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall as CSL faces FX headwinds
Incannex appoints experienced lead investigators for Phase-2/3 clinical trial into sleep apnoea
ASX Health Stocks: Sub $50m market cap Austco nabs $7.4m contract, the biggest in its history
Weed Week: Storm before the calm as cannabis market set to boom after SAFE Banking Act passed
Healthy snacks: Forbidden Foods gains traction in US with Blue Dinosaur brand
ASX Health Stocks: All about closing deals this morning as HeraMED and Careteq sign new contracts
ASX Health Stocks: Clarity to expand Phase 3 trial sites; CSL downgrades profit on FX headwinds
Bioxyne positions for growth following Breathe Life Sciences acquisition
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
